A Study of RAY1225 in Participants With Type 2 Diabetes
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-12-20
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to learn more about the Tolerability of RAY1225 in participants with type 2 diabetes mellitus. The study will also explore the efficacy of RAY1225. The study will last about six months for each participant.